Showing results (1161-1170 of 1,628) with videos related to

Sort By:
Pageof 163
The International Journal of Biological Markers|September 28, 2012
Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapyRimoun R Boutrus, Rita F Abi Raad, Irene Kuter, et al.
The International Journal of Biological Markers|September 28, 2012
Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival dataYao Chen, Cuihua Yi, Lian Liu, et al.
The International Journal of Biological Markers|January 31, 2015
Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissuesSodai Narumi, Yasuhiro Miki, Shuko Hata, et al.
The International Journal of Biological Markers|August 7, 2012
Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patientsThijs Roelofsen, Marjanka Mingels, Jan C M Hendriks, et al.
The International Journal of Biological Markers|August 7, 2012
Insulin glargine and risk of cancer: a meta-analysisXinli Du, Rihua Zhang, Yi Xue, et al.
The International Journal of Biological Markers|July 3, 2020
Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancerHui Xu, Bengtong Yu, Weiyu Shen, et al.
The International Journal of Biological Markers|February 24, 2015
Moving from discovery to validation in circulating microRNA researchPaolo Verderio, Stefano Bottelli, Chiara M Ciniselli, et al.
The International Journal of Biological Markers|March 23, 2010
No mutation detected in five hot spot codons of the TP53 gene by restriction site mutation analysis in patients with carcinoma of the tongueHemangini H Vora, Shalvi V Mehta, Shilin N Shukla, et al.
The International Journal of Biological Markers|March 23, 2010
Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusionsJaromir Kotyza, David Havel, Jindra Vrzalová, et al.
The International Journal of Biological Markers|February 17, 2015
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant settingMasakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, et al.
Pageof 163